Deep learning enhanced transmembranous electromyography in the diagnosis of sleep apnea.

Obstructive sleep apnea (OSA) is widespread, under-recognized, and under-treated, impacting the health and quality of life for millions. The current gold standard for sleep apnea testing is based on the in-lab sleep study, which is costly, cumbersome, not readily available and represents a well-known roadblock to managing this huge societal burden. Assessment of neuromuscular function involved in the upper airway using electromyography (EMG) has shown potential to characterize and diagnose sleep apnea, while the development of transmembranous electromyography (tmEMG), a painless surface probe, has made this opportunity practical and highly feasible.

Peritoneal Cancer Index Correlates with Radiographic Assessment of Colorectal Carcinomatosis.

Background: The Peritoneal Cancer Index (PCI), calculated intraoperatively, has previously yielded mixed results when correlated with computed tomography. This study aimed to quantify variation in this scoring method comparing radiologists' and surgeons' radiologic PCI (rPCI) assessment.

Methods: The rPCI of 104 patients treated at a single institution for peritoneal carcinomatosis was calculated by an abdominal radiologist and a surgeon.

Dermatology Program Coordinators' Role and Insight in the Resident Selection Process.

Background: With the evolution of residency applications and the myriad of roles that program coordinators (PCs) undertake, there is a gap in the medical education literature surrounding PCs' role in the resident selection process.

Objective: We sought to quantify the role of Dermatology residency PCs in the resident selection process and the unique perspective they gain from their interactions with applicants.

Methods: PC- and program director (PD)-specific surveys were designed and distributed in 2023 via email to Dermatology PDs via the Association of Professors of Dermatology (APD) listserv and to PCs via email using the contact information found on publicly available residency program websites.

Ten-Year Outcome of a Randomized Trial: Cytoreduction and HIPEC with Mitomycin C Versus Oxaliplatin for Appendiceal Neoplasm with Peritoneal Dissemination.

Background: Appendiceal cancer is a rare disease that has proven difficult to study in prospectively. Our initial report of this trial showed minor hematologic toxicity with both mitomycin C and oxaliplatin and similar 3-year survival. We now report an update of the first prospective randomized trial for appendiceal cancer with 10-year follow up.